Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studied and the trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrinoma
• Gastrointestinal Carcinoid Tumor
• Glucagonoma
• Insulinoma
• Islet Cell Carcinoma
• Pancreatic Polypeptide Tumor
• Pulmonary Carcinoid Tumor
• Somatostatinoma

Drugs mentioned

• Romidepsin (romidepsin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastrinoma, Glucagonoma | Phase 2 | Status: TERMINATED